faDe engelstalige briefing Chewing over Khat Prohibition rekent af met de effectiviteit van een ban, zoals is gebleken uit andere Europese landen. Problematisch gebruik hangt nauw samen met andere social problemen en is geen reden tot verbod. Andere oplossingen zijn te prefereren.
Today the International Narcotics Control Board (INCB) released its annual report. I’ve been following the Board for many, many years now, have often criticized its narrow interpretation of the treaties, have questioned the validity of its usually negative comments about any policy changes in the direction of harm reduction or decriminalization, and have warned repeatedly about its tendency to overstep its clearly defined mandate.
On the basis of the available evidence, the overwhelming majority of Council members consider that khat should not be controlled under the Misuse of Drugs Act 1971. In summary the reason for this is that, save for the issue of liver toxicity, although there may be a correlation or association between the use of khat and various negative social indicators, it is not possible to conclude that there is any causal link.
Today, khat joined the range of prohibited substances that fall under the UK Misuse of Drugs Act 1971. Those who distribute this Class C drug can now face 14 years imprisonment – the same maximum sentence that applies to individuals who cause death by dangerous driving, and four years more than the maximum penalty for sexual assault. So what exactly is khat, and why has it attracted such harsh legislation? (See also: Khat: Update - Ban to be implemented on the 24th of June)
In the context of a fast changing and well documented market in legal highs, the case of khat (Catha edulis) provides an interesting anomaly. It is first of all a plant-based substance that undergoes minimal transformation or processing in the journey from farm to market. Secondly, khat has been consumed for hundreds if not thousands of years in the highlands of Eastern Africa and Southern Arabia. In European countries, khat use was first observed during the 1980s, but has only attracted wider attention in recent years.
E.J.M. Pennings, A. Opperhuizen, J.G.C. van Amsterdam
22 August 2008
In preparing a decision about the legal status of khat in the Netherlands, the Dutch Minister of Health requested CAM (Coordination point Assessment and Monitoring new drugs) to assess the overall risk of khat in the Netherlands. The present paper is a redraft of a report which formed the scientific basis of the risk evaluation procedure (October 2007). This report reviews the scientific data about khat available in the international literature. In addition, the report contains some information specific for the Netherlands (prevalence, availability of khat and public order aspects).
Within the last decade the hitherto little known psychoactive substance of khat has emerged as a regional and international issue. In the Horn of Africa khat production has spurred an economic boom, but dramatic increases in consumption have raised public health concerns. Given the complexity of the topic spanning multiple academic disciplines and fields of professional practice, the need for a systematic overview is urgent.